Systemic immunity markers associated with lymphocytes predict the survival benefit from paclitaxel plus bevacizumab in HER2 negative advanced breast cancer von Nakamoto, Shogo, Ikeda, Masahiko, Kubo, Shinichiro, Yamamoto, Mari, Yamashita, Tetsumasa, Notsu, Akifumi

Volltext

Is the presence of edema and necrosis on T2WI pretreatment breast MRI the key to predict pCR of triple negative breast cancer? von Harada, Taiyo L., Uematsu, Takayoshi, Nakashima, Kazuaki, Sugino, Takashi, Nishimura, Seiichirou, Takahashi, Kaoru, Hayashi, Tomomi, Tadokoro, Yukiko, Watanabe, Junichiro, Nakamoto, Shogo, Ito, Takahiro

Volltext

Shorter duration of first-line chemotherapy reflects poorer outcomes in patients with HER2-negative advanced breast cancer: a multicenter retrospective study von Nakamoto, Shogo, Watanabe, Junichiro, Ohtani, Shoichiro, Morita, Satoshi, Ikeda, Masahiko

Volltext

Leptomeningeal Metastasis in ER + HER2- Advanced Breast Cancer Patients: A Review of the Cases in a Single Institute Over a 15-year Period von Watanabe, Junichiro, Mitsuya, Koichi, Nakamoto, Shogo, Harada, Hideyuki, Deguchi, Shoichi, Hayashi, Nakamasa, Nakasu, Yoko

Volltext

Eribulin improved the overall survival from the initiation of first-line chemotherapy for HER2-negative advanced breast cancer: a multicenter retrospective study von Nakamoto, Shogo, Watanabe, Junichiro, Ohtani, Shoichiro, Morita, Satoshi, Ikeda, Masahiko

Volltext

Absolute lymphocyte count and neutrophil-to-lymphocyte ratio as predictors of CDK 4/6 inhibitor efficacy in advanced breast cancer von Nakamoto, Shogo, Shien, Tadahiko, Iwamoto, Takayuki, Kubo, Shinichiro, Yamamoto, Mari, Yamashita, Tetsumasa, Kuwahara, Chihiro, Ikeda, Masahiko

Volltext

Systemic immunity markers are associated with clinical outcomes of atezolizumab treatment in patients with triple-negative advanced breast cancer: a retrospective multicenter obser... von Nakamoto, Shogo, Shien, Tadahiko, Itoh, Mitsuya, Yamamoto, Yutaka, Ohsumi, Shozo, Yoshitomi, Seiji, Hikino, Hajime, Miyoshi, Kazuya, Notsu, Akifumi, Taira, Naruto, Doihara, Hiroyoshi, Ikeda, Masahiko

Volltext

Ectopic Breast Cancer Arising within an Axillary Lymph Node von Toshima, Kei, Shien, Tadahiko, Nishimura, Midori Filiz, Suzuki, Yoko, Nakamoto, Shogo, Uno, Maya, Yoshioka, Ryo, Tsukioki, Takahiro, Takahashi, Yuko, Iwamoto, Takayuki, Iwatani, Tsuguo, Yanai, Hiroyuki

Volltext

PO93 - ADVANCED INVASIVE LOBULAR CARCINOMA, REAL WORLD EXPERIENCES IN SINGLE INSTITUTION von Watanabe, Junichiro, Nakamoto, Shogo

Volltext

ADVANCED INVASIVE LOBULAR CARCINOMA, REAL WORLD EXPERIENCES IN SINGLE INSTITUTION von Watanabe, Junichiro, Nakamoto, Shogo

Volltext

Imaging Features of Breast Cancer with Marked Hemosiderin Deposition: A Case Report von Harada, Taiyo L, Nakashima, Kazuaki, Uematsu, Takayoshi, Sugino, Takashi, Nishimura, Seiichirou, Takahashi, Kaoru, Tadokoro, Yukiko, Hayashi, Tomomi, Watanabe, Junichiro, Nakamoto, Shogo

Volltext

MO19-3 PD-L1 expression in patients with HER2-negative advanced breast cancer: A multicenter retrospective study von Watanabe, Junichiro, Takashi, Sugino, Koji, Muramatsu, Satoshi, Morita, Yu, Hidaka, Shogo, Nakamoto, Mitsuya, Ito, Shoichiro, Ohtani, Masahiko, Ikeda

Volltext

Bevacizumab as First-line Treatment for HER2-negative Advanced Breast Cancer: Paclitaxel plus Bevacizumab Versus Other Chemotherapy von Nakamoto, Shogo, Watanabe, Junichiro, Ohtani, Shoichiro, Morita, Satoshi, Ikeda, Masahiko

Volltext

De-escalated Therapy Omitting Anthracyclines for Stage I HER2-positive Breast Cancer: A Retrospective Observational Study von Nakamoto, Shogo, Ikeda, Masahiko, Kubo, Shinichiro, Yamamoto, Mari, Yamashita, Tetsumasa

Volltext

Baseline gut microbiota as a predictive marker for the efficacy of neoadjuvant chemotherapy in patients with early breast cancer: a multicenter prospective cohort study in the Seto... von Nakamoto, Shogo, Kajiwara, Yukiko, Taniguchi, Kohei, Hida, Akira I., Miyoshi, Yuichiro, Kin, Takanori, Yamamoto, Mari, Takabatake, Daisuke, Kubo, Shinichiro, Hikino, Hajime, Ogasawara, Yutaka, Ikeda, Masahiko, Doihara, Hiroyoshi, Shien, Tadahiko, Taira, Naruto, Iwamoto, Takayuki, Toyooka, Shinichi

Volltext

Radiation hepatitis after postmastectomy radiation therapy for early breast cancer: difficult to differentiate from drug-induced liver injury caused by abemaciclib von Nakamoto, Shogo, Waki, Takahiro, Mimata, Asuka, Tsukioki, Takahiro, Takahashi, Yuko, Iwatani, Yoko, Iwatani, Tsuguo, Shien, Tadahiko

Volltext

Primary angiosarcoma of the breast: a literature review von Zhu, Yidan, Nakamoto, Shogo, Tsukioki, Takahiro, Takahashi, Yuko, Iwatani, Yoko, Iwatani, Tsuguo, Zhang, Xinfeng, Tanioka, Maki, Shien, Tadahiko

Volltext

The effect of exercise and educational programs for breast cancer patients on the development of breast cancer-related lymphoedema: secondary endpoint from a randomized controlled... von Nakamoto, Shogo, Iwamoto, Takayuki, Taira, Naruto, Kajiwara, Yukiko, Kawada, Kengo, Takabatake, Daisuke, Miyoshi, Yuichiro, Kubo, Shinichiro, Suzuki, Yoko, Yamamoto, Mari, Ogasawara, Yutaka, Hatono, Minami, Yoshitomi, Seiji, Hara, Kyoko, Sasahara, Asako, Ohsumi, Shozo, Ikeda, Masahiko, Doihara, Hiroyoshi, Mizota, Yuri, Yamamoto, Seiichiro, Shien, Tadahiko, Toyooka, Shinichi

Volltext

Abstract P5-02-48: Identifying immune-related predictive factors for paclitaxel + bevacizumab therapy in patients with HER2-negative advanced breast cancer- A multicenter retrospec... von Watanabe, Junichiro, Sugino, Takashi, Muramatsu, Koji, Morita, Satoshi, Hidaka, Yu, Nakamoto, Shogo, Ito, Mitsuya, Ohtani, Shoichiro, Ikeda, Masahiko

Volltext

INFORMATION PROVISION DEVICE von NAKAMOTO, Shogo

Volltext bestellen